China SXT Pharmaceuticals, Inc. (SXTC) Free cash flow 2017–2025
China SXT Pharmaceuticals, Inc. (SXTC) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$2.3MFY2025 · since FY2017: $113,866 → -$2.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$2.3M | -21.3% |
| FY2024 | -$1.9M | — |
| FY2020 | $803,408 | +370.8% |
| FY2019 | -$296,633 | -120.0% |
| FY2018 | $1.5M | +1203.4% |
| FY2017 | $113,866 | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice